Roche will publish its Full Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 2 February 2023.

07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before)

Release will be e-mailed and posted on the Roche IR website >click here
Presentation slides will be posted on the Roche IR website >click here

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

  • Severin Schwan, CEO Roche Group
  • Thomas Schinecker, CEO Roche Pharmaceuticals ad interim
  • Matt Sause, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here *

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via >ir.roche.com
*privacy notice

Best regards,

Attachments

Disclaimer

Roche Holding AG published this content on 26 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2023 16:17:02 UTC.